Active Filters
- 2022Clear filter
Dec 23, 2022
Dec 19, 2022
Four decades of NCI-funded NCTN trials gave U.S. patients 14.2 million life-years for a federal investment of $326 per life-year gained
Dec 16, 2022
14+ million years of life come from an astonishingly modest investment
Dec 9, 2022
Nov 23, 2022
Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens
Nov 21, 2022
SWOG researchers will present 10 abstracts at SABCS 2022. Here are highlights.
Nov 18, 2022